DEV BHOOMI PHARMACEUTICALS appears as a bidder on 7 government tenders on record, from 1 buyer authority on central and PSU portals. Of its 6 decided bids, it was awarded 3 — a 50.0% win rate — worth ₹170 in total. Its most recent award on record is from 20 May 2026.
Its largest buyer by awarded value is Municipal Corporation of Delhi, at 100.0% of what it has won. On priced bids, its median quote is 135.7% above the lowest bid (L1).
It most often bids against Medipol Pharmaceutical India Pvt Ltd, Mankind Pharma Limited and Unijules Life Sciences Ltd.. Medipol Pharmaceutical India Pvt Ltd bid on 5 of the same tenders and won 4 of them; DEV BHOOMI PHARMACEUTICALS won 2.
This profile is built from what portals disclose publicly. Several states never release bidder lists or quoted prices, so it likely understates a company's true footprint. Companies are matched by the name they bid under, so firms sharing a common name can appear together. A tender counts as won when the company received the award. TenderShark compiles these public records independently and has no association with any government portal, buyer, or bidder.